EpiPen maker seeks meeting with Chuck Grassley over subpoena threat, report says

Published



Representatives from the drugmaker Mylan want to meet with Sen. Chuck Grassley, R-Iowa, to discuss a probe into whether the company bilked Medicaid out of $1.27 billion, according to a published report.

Mylan, which produces the allergy drug EpiPen, wants to meet with Grassley on June 7 to discuss a subpoena threat over documents pertaining to Medicaid’s rebate program, according to a report in the Street.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.